Skip to main content
News Jung 09.2021
AG Jung: Julia Steinberg, Timo Wadenpohl, Jun. Prof. Dr. Stephanie Jung
© Katharina Wislsperger / UKB

News categories: Publication

How danger signaling is amplified in Influenza A-virus infected cells

Young research goup around Cluster Member Stephanie Jung shows how danger signaling is amplified in Influenza A-virus infected cells.

Influenza virus-induced acute respiratory infections occur in all parts of the world and represent a constant disease-burden. While the seasonal epidemic outbreaks are caused by Influenza-subtypes A and B, only Influenza-A strains are reported to have caused pandemic spreads. Overall, Influenza-A infections account for 250,000 to 300,000 deaths p.a.

To protect us from microbial threats, the innate immune system provides several immune sensing receptors. These recognize foreign microbial molecules and induce an immunological response. RNA-viruses like Influenza-A and Hepatitis-C are detected by the intracellular receptor RIG-I (retinoic acid inducible gene I). RIG-I binds to double-stranded viral RNA and hairpin structures of viral genomes. Upon activation, the receptor multimerizes and ultimately induces the cellular release of antiviral cytokines.

In a previous publication, Stephanie Jung and colleagues already described the role of endogenous RNA in an amplified RIG-I activation: Recognition of viral RNA by oligoadenylate synthase leads to activation of RNase L, which cleaves endogenous ribosomal RNAs. The resulting fragment acts as endogenous RIG-I ligand (eRL) and thereby amplifies the RIG-I mediated response to the viral thread.

Stephanie Jung and her team now provide evidence that eRL is generated in Influenza-A infected cells. Further they could show that the activation of RIG-I by eRL is independent of the direct recognition of viral RNAs by the receptor. The work thereby provides the foundation for further research on the physiological function of eRLs and their role in other viral infections.

Remarkably, the paper was published only a few months into first-author Julia Steinbergs PhD project, who started her work with Stephanie Jung in April 2021. “Sometimes things just run perfectly – even in the lab” Julia states. It is important to enable young scientists to publish early on during their PhD, Stephanie Jung is convinced. “With her first publication in hand, Julia can now pursue her main project with the maximum freedom possible”.

It is also the first publication for Stephanie Jung as Junior Professor for Cellular Virology and member of the Cluster of Excellence Immunosensation2. As group leader at the institute of Cardiovascular Immunology, her research is focused on the identification of immune-activating viral RNAs and the role of extracellular vesicles in viral infections.


Participating institutions and funding

The project was funded by the German Research Foundation (DFG) under the Germany’s Excellence Strategy – EXC2151 – 390873048.


Publication

Julia Steinberg, Timo Wadenpohl, Stephanie Jung: The Endogenous RIG-I Ligand Is Generated in Influenza A-Virus Infected Cells. Viruses. https://www.mdpi.com/1999-4915/13/8/1564


Contact

Jun. Prof. Dr. Stephanie Jung

University Bonn

University Hospital Bonn

stephanie.jung@ukbonn.de

Related news

News Icon

News categories: Publication

B cells maintain antigen presentation in the splenic marginal zone

A team of international researchers, including ImmunoSensation³ members Prof. Niels Lemmermann and Prof. Andreas Schlitzer, shows that B cells support antiviral CD8⁺ T-cell responses beyond antibody production. In a murine CMV model, B-cell deficiency weakened virus-specific CD8⁺ T-cell responses. Mechanistically, B-cell-derived lymphotoxin β maintained CD169⁺ macrophages and Langerin⁺ cDC1 cells in the splenic marginal zone, enabling efficient T-cell priming. The study was published in Cellular & Molecular Immunology.
Full publication
News Ludwig

News categories: Publication

New findings on infection with the Epstein-Barr virus

The Epstein-Barr virus (EBV) can cause certain types of cancer or autoimmune diseases, but how the body controls this common viral infection is largely unknown. Bonn researchers have now identified genetic and non-genetic factors that help the body fight EBV. To do this, they evaluated genome sequencing data, which is actually intended for characterizing the human genome, in a new way. Using the new technique, they were able to estimate the amount of EBV in the blood and find correlations in large health data sets. Their findings have now been published in the renowned journal Nature.
View entry
News Icon

News categories: Publication

New insights into the human immune defense against poxviruses

An international research team involving Bonn scientist has made an important contribution to understanding the human immune response to poxviruses: The scientists were able to show for the first time that different human cell types recognize poxviruses via different sensors in order to trigger inflammatory responses. At the same time, the team developed the world's first nanobodies that can specifically block the DNA sensor AIM2 – a tool that opens up new possibilities for inflammation and infection research. The paper has now been published in The EMBO Journal.
View entry

Back to the news overview